Arizona Health Sciences

Publications

Year of Publication Title Faculty Association
2014 Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. Tally Largent-Milnes, Ph.D.
2014 Animal models for opioid addiction drug discovery. Tally Largent-Milnes, Ph.D., Todd Vanderah, Ph.D.
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Yeon Sun Lee, Ph.D., Frank Porreca, Ph.D., Todd Vanderah, Ph.D., Yanhua Xie, Ph.D.
2014 Three-dimensional printing surgical instruments: are we there yet? George Watts, Ph.D.
2014 Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons. Tally Largent-Milnes, Ph.D.
2014 Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. Nam Lee, Ph.D.
2014 Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt. John M. Streicher, PhD
2014 Estrogen: a master regulator of bioenergetic systems in the brain and body. Roberta Diaz Brinton, Ph.D
2014 Environmental arsenic exposure and microbiota in induced sputum. George Watts, Ph.D.
2014 Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study. Roberta Diaz Brinton, Ph.D
2014 Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise. Roberta Diaz Brinton, Ph.D
2014 External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. Tally Largent-Milnes, Ph.D.
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2014 Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. Patrick T Ronaldson, Ph.D.
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. Rajesh Khanna, Ph.D., May Khanna, Ph.D.
2014 Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Roberta Diaz Brinton, Ph.D
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, Ph.D.
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury. Rajesh Khanna, Ph.D.
2014 The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. Rajesh Khanna, Ph.D., May Khanna, Ph.D.
2014 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. George Watts, Ph.D.
2013 Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Tally Largent-Milnes, Ph.D., Edita Navratilova, Ph.D., Frank Porreca, Ph.D., Todd Vanderah, Ph.D.
2013 Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. Victor Hruby, Ph.D., Tally Largent-Milnes, Ph.D., Frank Porreca, Ph.D., Todd Vanderah, Ph.D.
2013 Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism. Thomas P Davis, Ph.D., Patrick T Ronaldson, Ph.D., Todd Vanderah, Ph.D.
2013 Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Roberta Diaz Brinton, Ph.D
2013 Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Roberta Diaz Brinton, Ph.D

Pages